Details for New Drug Application (NDA): 018928

✉ Email this page to a colleague

NDA 018928 describes PENNTUSS, which is a drug marketed by Fisons and is included in one NDA. Additional details are available on the PENNTUSS profile page.

The generic ingredient in PENNTUSS is chlorpheniramine polistirex; codeine polistirex. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.

Summary for 018928

Tradename:	PENNTUSS
Applicant:	Fisons
Ingredient:	chlorpheniramine polistirex; codeine polistirex
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SUSPENSION, EXTENDED RELEASE;ORAL			Strength	EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML
Approval Date:	Aug 14, 1985	TE:		RLD:	No

Expired US Patents for NDA 018928

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Fisons	PENNTUSS	chlorpheniramine polistirex; codeine polistirex	SUSPENSION, EXTENDED RELEASE;ORAL	018928-001	Aug 14, 1985	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.